JPRN-UMIN000000682招募中未知
Treatment of retinal vein occulusion - Treatment of RVO
Department of Ophthalmology,Yamagata University, School of Medicine0 个研究点目标入组 30 人开始时间: 2007年4月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who did not agree with this study. Patients who rised of intraocular pressure by using steroid eye drops.
研究者
相似试验
撤回
2 期
Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)Retinal Vein OcclusionNCT00211354Manhattan Eye, Ear & Throat Hospital
已完成
2 期
REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab StudyMacular EdemaBranch Retinal Vein OcclusionNCT01247220Retina Associates of Florida, P.A.12
进行中（未招募）
不适用
uRVO:Classification of Central Retinal Vein Occlusion and Management with Lucentis (Ranibizumab) - a randomised clinical trial. - LURVOCentral nethindeveneokklusion (e. central retinal vein occlusion, CRVO)MedDRA version: 9.1Level: LLTClassification code 10007972Term: Central retinal vein occlusionMedDRA version: 9.1Level: LLTClassification code 10054467Term: Macular edemaMedDRA version: 9.1Level: LLTClassification code 10029114Term: NeovascularizationEUCTR2009-012941-45-DKGlostrup Hospital50
招募中
2 期
Intraretinal vessel treatment for central retinal vein occlusioCetntral Retinal Artery and Vein OcclusionJPRN-UMIN000007958Intraretinal vessel treatment for central retinal vein occlusion study team10
已完成
3 期
Bevacizumab for Central Retinal Vein Occlusion StudyCentral Retinal Vein OcclusionNCT00906685Anders Kvanta60